Ocular Melanoma Clinical Trial
Official title:
Prospective Registry of Ocular Melanoma Eye Plaque brachyTherapy Patients (PROMPT)
This prospective registry study will evaluate doses utilized in eye plaque brachytherapy for the treatment of ocular melanoma and their associated outcomes. The goal of this study is to evaluate if lower doses of radiation can maintain high local control rates while minimizing the toxicities related to radiation therapy.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04364230 -
Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma)
|
Phase 1/Phase 2 | |
Completed |
NCT01200238 -
STA-9090(Ganetespib) in Metastatic Ocular Melanoma
|
Phase 2 | |
Completed |
NCT02858869 -
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
|
Phase 1 | |
Completed |
NCT01355120 -
THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease
|
Phase 2 | |
Recruiting |
NCT05524935 -
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
|
Phase 2 | |
Recruiting |
NCT05628883 -
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
|
Phase 1 | |
Active, not recruiting |
NCT05187884 -
Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma
|
Phase 2 | |
Recruiting |
NCT02909517 -
The Role of Inflammation in Ocular Tumours
|
||
Withdrawn |
NCT00621439 -
Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye
|
N/A | |
Terminated |
NCT00346372 -
Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
|
||
Recruiting |
NCT03172299 -
Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma
|
Phase 3 | |
Completed |
NCT01893099 -
Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
|
Phase 1 | |
Completed |
NCT00351728 -
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
|
N/A | |
Active, not recruiting |
NCT03528408 -
Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma
|
Phase 2 | |
Completed |
NCT03052127 -
Study in Subjects With Small Primary Choroidal Melanoma
|
Phase 1/Phase 2 | |
Withdrawn |
NCT01930968 -
Definity for Ultrasound of Intraocular Tumors
|
||
Recruiting |
NCT00168870 -
Study of Metastatic Ocular Melanoma
|
Phase 2 | |
Completed |
NCT02519322 -
Neoadjuvant and Adjuvant Checkpoint Blockade
|
Phase 2 | |
Recruiting |
NCT06007690 -
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
|
Phase 3 | |
Active, not recruiting |
NCT04417530 -
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
|
Phase 2 |